Product
Fecal Microbiota Transplant
Aliases
Fecal Microbiota Transplant (FMT), FMT
9 clinical trials
18 indications
Indication
Clostridium difficile infectionIndication
Lung CancerIndication
melanomaIndication
Head and Neck Squamous Cell CarcinomaIndication
Cutaneous Squamous Cell CarcinomaIndication
MSI-HighIndication
Renal Cell CarcinomaIndication
Infection Due to Resistant OrganismIndication
Clostridium difficileIndication
Inflammatory Bowel DiseaseIndication
Crohn's diseaseIndication
ulcerative colitisIndication
Crohn's DiseaseIndication
Hepatic EncephalopathyIndication
Acute Myeloid LeukemiaIndication
Chronic PouchitisIndication
PouchitisClinical trial
Phase II Feasibility Study of Responder-derived FMT (R-FMT) and Pembrolizumab in Relapsed/Refractory PD-L1 Positive NSCLCStatus: Not yet recruiting, Estimated PCD: 2029-07-31
Clinical trial
MITRIC: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clincal RespondersStatus: Recruiting, Estimated PCD: 2034-03-31
Clinical trial
A Pilot Study Using Fecal Microbiota Transplant in Renal Transplant Recipients to Eliminate Multidrug-Resistant Organism Colonization After Infection and Examine Gastrointestinal Carriage in a Randomized Placebo-Controlled DesignStatus: Terminated, Estimated PCD: 2021-12-03
Clinical trial
Fecal Microbiome Transplant in Pediatric C. DifficileStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's ColitisStatus: Completed, Estimated PCD: 2019-04-08
Clinical trial
Fecal Microbiota Transplant as Treatment of Hepatic EncephalopathyStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
A Randomized Placebo-Controlled Clinical Trial of Fecal Microbiota Transplantation in Patients With Acute Myeloid Leukemia and Allogeneic Hematopoietic Cell Transplantation RecipientsStatus: Completed, Estimated PCD: 2022-02-11
Clinical trial
Safety and Efficacy of Healthy to Inflamed Pouch Fecal Microbiota TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-12-01